Home Treatments NAD+ Injectable
The flagship cellular energy protocol. Restore the molecule every cell uses to convert nutrients into ATP, the energy that powers your day.
Pause or cancel anytime
NAD+ is the molecule every cell uses to make energy. Levels drop steadily after 30 — by 50, healthy adults are at roughly half their 20-year-old levels. That drop is the rate-limiting step on mitochondrial output.
Injectable NAD+ rebuilds the pool faster than oral. Subcutaneous bypasses first-pass metabolism. Most patients describe sharper mornings, steadier afternoons, and better post-workout recovery inside the first month.
It's one of the most-studied longevity targets in literature. Sinclair, Imai, Verdin labs have tracked NAD+ for two decades. We use it because the data is real, not because it's trending.
Your protocol is written by a US-licensed clinician based on your intake and goals. Compounded by a US-licensed pharmacy under USP <797> sterile standards. Cold-chain shipped to your door.
Weekly subcutaneous injection. Energy lift is typically the first thing patients notice; deeper effects show up over months.
Weekly dosing builds cellular NAD+ pools. First-week patients describe brighter mornings; gut and energy adjust over 7–10 days.
Background fatigue drops noticeably. Sharper afternoons and better post-workout recovery are the most-reported wins.
NAD+ pools sit elevated. Most continue weekly or step down to a bi-weekly maintenance dose.
Maintenance once goals are met. Many run 3–6 month cycles with rest periods on clinician advice.
Eligibility is determined by a US-licensed clinician based on your intake.
~50%
the drop in cellular NAD+ between age 20 and 60 — the rate-limiting step on mitochondrial energy output. Restoring it is what every longevity protocol aims at first.
Massudi et al., PLOS One 2012; Imai & Guarente, Trends in Cell Biology 2014Most patients describe an energy lift within 2–3 weeks of starting their protocol. Sleep quality and morning focus often shift first. Individual results vary.
The needle is small — comparable to an insulin pen. Self-injection is delivered under the skin (subcutaneous) in the abdomen or thigh. Care team walks you through your first dose on a video call if you want.
The most commonly reported side effects are flushing, mild nausea, and injection-site reactions. These typically subside within minutes to hours. Discuss any new therapy with your primary care provider.
Yes. Pause, skip a month, switch protocols, or cancel anytime from your portal. No phone tag, no fees.
NAD+ Injectable is a prescription compounded medication. A US-licensed clinician reviews your intake before any prescription is written, and your medication is compounded by a US-licensed pharmacy. Compounded medications are not themselves FDA-approved drugs; they are prepared for an individual patient based on a clinician's prescription.
NAD+ rebuilds cellular energy. The pairings below defend the new output, accelerate the stack, and keep results compounding.
